IENTILE, VALENTINA
 Distribuzione geografica
Continente #
AS - Asia 40
EU - Europa 38
NA - Nord America 23
SA - Sud America 11
AF - Africa 4
Totale 116
Nazione #
US - Stati Uniti d'America 23
SG - Singapore 16
HK - Hong Kong 10
DE - Germania 9
BR - Brasile 8
CN - Cina 8
FI - Finlandia 8
IT - Italia 7
RU - Federazione Russa 7
FR - Francia 3
NL - Olanda 3
AR - Argentina 2
TG - Togo 2
VN - Vietnam 2
AT - Austria 1
BH - Bahrain 1
CM - Camerun 1
CO - Colombia 1
IQ - Iraq 1
JP - Giappone 1
KR - Corea 1
SD - Sudan 1
Totale 116
Città #
Hong Kong 10
Singapore 9
Helsinki 6
Munich 5
Verona 4
Ashburn 3
Dallas 3
The Dalles 3
Brooklyn 2
Chions 2
Ho Chi Minh City 2
Lomé 2
Maastricht 2
Turku 2
Amsterdam 1
Basra 1
Beijing 1
Boardman 1
Buenos Aires 1
Changsha 1
Escada 1
Espírito Santo do Pinhal 1
Falkenstein 1
Frankfurt am Main 1
Indaiatuba 1
Isa Town 1
Itaquaquecetuba 1
La Consulta 1
Lombard 1
Moscow 1
New York 1
Nuremberg 1
Rio de Janeiro 1
Santa Clara 1
Santiago de Cali 1
São João del Rei 1
São Paulo 1
Tokyo 1
Vienna 1
Várzea Paulista 1
Wuhan 1
Totale 82
Nome #
Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of 66,639 biologic users from the Italian VALORE project 47
Comment on "Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project". [Response to Letter] 42
Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project 35
Totale 124
Categoria #
all - tutte 771
article - articoli 771
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.542


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202422 0 0 0 0 0 0 6 4 1 0 1 10
2024/202568 15 2 6 7 2 7 2 3 2 6 6 10
2025/202634 13 19 2 0 0 0 0 0 0 0 0 0
Totale 124